Company intelligence / Profile preview

Laboratoires Albert Rolland

Paris, France

Ownership: Private
Development stage: Other

Overview

Laboratoires Albert Rolland was a French pharmaceutical firm established in 1948 by Albert Rolland. The company focused on the development of cardiovascular and analgesic medications, achieving significant commercial success with the cardiac stimulant Heptamyl (heptaminol). In 1969, the company was acquired by Hoechst AG, marking a period of consolidation that eventually integrated the firm into Roussel Uclaf. Following a series of global pharmaceutical mergers, the company's assets and product portfolio became part of Sanofi. Today, Laboratoires Albert Rolland exists as a legacy entity within the Sanofi group.

Therapeutic areas: CardiovascularImmunologyNeurology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Laboratoires Albert Rolland.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratoires Albert Rolland.

Explore the full profile